• Patient
  • Klinische Anwender
  • Forschungs Anwender
  • Über uns
Vivosight (Deutsch)
  • VivoSight-Scanner
    • Funktion
    • Häufig gestellte fragen
  • Untersuchungsablauf
  • Hautkrebs
    • Daten und Fakten
  • Kontakt
    • Scanner in Ihrer Nähe
  • Search
▼International (DE)
International (EN)
United States

Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery

Cunha D, Richardson T, Sheth N, Orchard G, Coleman A, Mallipeddi R. /Br J Dermatol./28th July 2011
Read more →

Optical Coherence Tomography: A new tool to assess nail disease in psoriasis?

Aydin S. Z, Ash Z, Del Galdo F, Marzo-Ortega H, Wakefield R. J, Emery P, McGonagle D./Dermatology./25th July 2011
Read more →

Optical Coherence Tomography Used for Monitoring of PDT Treatment of Superficial Basal Cell Carcinomas

Themstrup L, Mogensen M, Jemec, G. B./15th July 2011
Read more →

Optical Coherence Tomography in Dermatology: Technical and Clinical Aspects

Gambichler T, Jaedicke V, Terras S. /Arch Dermatol Res./7th June 2011
Read more →

Optical coherence tomography-guided photodynamic therapy for skin cancer: Case study

Hamdoon Z, Jerjes W, Upile T, Hopper C./Photodiagnosis Photodyn Ther./24th March 2011
Read more →

Optical coherence tomography in the evaluation of tongue papillae in healthy individuals

Hamdoon Z, Jerjes W, Hopper C./British Journal of Oral and Maxillofacial Surgery/8th March 2011
Read more →

Clinical optical coherence tomography combined with multiphoton tomography for evaluation of several skin disorders

Konig K, Speicher M, Buckle R, Reckfort J, McKenzie G, Welzel J, Koehler M. J, Elsner P, Kaatz M./J Biophotonics./2nd July 2009
Read more →
Page 4 of 41234

Recent Posts

  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • (no title)

Categories

  • Appointments
  • Autoimmun-Erkrankungen
  • Clinical Evidence
  • Corporate
  • Corporate
  • Entzündliche Erkrankungen
  • Events
  • Financing
  • Klinische Anwendung
  • Media Coverage
  • Nagelpilz und Erkrankungen des Nagelapparates
  • News
  • Nicht-melanozytäre Haut-Tumore und aktinische Keratose
  • OCT
  • Präoperative Tumorrand-Bestimmung
  • Press Release
  • Uncategorised
  • VivoSight
  • VivoSight
  • Weitere Anwendungen in der Dermatologie und Übersichtsartikel
  • Wundheilung, Narben und Verbrennungen

MICHELSON DIAGNOSTICS

Über uns
Karriere
Das Team
Aktuelles

 

 

KONTAKT

Agentur:
DermoScan GmbH
Ohmstraße 1, D-93055 Regensburg

T: +49 (0) 941 599 525 0
F: +49 (0) 32 211089 90002

E: info.de@vivosight.com

LEGAL

Impressum
Datenschutzerklärung
Cookie policy

Scroll to top